Package 11673-689-05

{"route": ["OPHTHALMIC"], "spl_id": "9c7c23fe-8fd3-d3b0-1410-83df55fa5db2", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111339"], "spl_set_id": ["02c27305-b2e8-aef3-0554-84a5db8a4695"], "manufacturer_name": ["Target Corporation"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (11673-689-05)  / 5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "11673-689-05", "marketing_start_date": "20211022"}], "brand_name": "Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "11673-689_9c7c23fe-8fd3-d3b0-1410-83df55fa5db2", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "11673-689", "generic_name": "Olopatadine Hydrochloride Ophthalmic Solution", "labeler_name": "Target Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA209619", "marketing_category": "ANDA", "marketing_start_date": "20211022", "listing_expiration_date": "20261231"}